NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 83 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is 473.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $789,000 | -13.9% | 489,814 | -15.0% | 0.08% | -14.4% |
| Q1 2015 | $916,000 | +2444.4% | 576,276 | +2008.5% | 0.09% | +2900.0% |
| Q3 2014 | $36,000 | -83.3% | 27,331 | -81.3% | 0.00% | -82.4% |
| Q2 2014 | $216,000 | -60.4% | 145,866 | -50.5% | 0.02% | -52.8% |
| Q1 2014 | $545,000 | -37.0% | 294,855 | -29.5% | 0.04% | -12.2% |
| Q4 2013 | $865,000 | – | 418,074 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 10,375,329 | $13,549,000 | 19.76% |
| Catalyst Capital Advisors LLC | 790,000 | $1,635,000 | 0.53% |
| DSC Advisors, L.P. | 500,000 | $1,035,000 | 0.50% |
| STONERIDGE INVESTMENT PARTNERS LLC | 142,528 | $295,000 | 0.06% |
| Hudock, Inc. | 30,500 | $63,000 | 0.05% |
| BRR OpCo, LLC | 52,700 | $109,000 | 0.05% |
| TFS CAPITAL LLC | 418,074 | $865,000 | 0.04% |
| LifePlan Financial Group, Inc | 28,810 | $60,000 | 0.04% |
| NOMURA HOLDINGS INC | 3,831,177 | $7,947,000 | 0.04% |
| BOLTON LP | 77,400 | $160,000 | 0.03% |